🌐 ESMO Congress

A comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science, highlight the first announcements of potentially practice-changing data, and stimulate multidisciplinary discussions aimed at improving treatment options for patients.

The ESMO Congress 2026 will bring together the global oncology community in Madrid for one of the year’s most influential scientific gatherings. As a central platform for presenting major advances in cancer research and clinical practice, the meeting will showcase the newest data across solid tumours, haematologic malignancies, and emerging therapeutic fields.

Under the scientific leadership of Congress President Fabrice André, with Scientific Co-Chairs Yelena Janjigian and James Larkin, and Educational Chair Nadia Harbeck, the 2026 program is designed to deliver high-impact scientific updates and expertly curated educational content. Attendees can expect presentations of practice-changing clinical trials, innovations in immuno-oncology and targeted therapy, advances in precision diagnostics, and insights from translational research shaping future treatments.

ESMO 2026 offers an essential opportunity to stay informed on evolving standards of care, connect with leading experts from around the world, and engage in multidisciplinary discussion that drives progress in oncology. With its broad scope and strong scientific focus, the congress continues to be a key meeting point for clinicians, researchers, and professionals committed to improving cancer outcomes globally.